Literature DB >> 3155619

Predictive value of early maximal exercise test and thallium scintigraphy after successful percutaneous transluminal coronary angioplasty.

W Wijns, P W Serruys, M L Simoons, M van den Brand, P J de Feijter, J H Reiber, P G Hugenholtz.   

Abstract

Restenosis of the dilated vessel after percutaneous transluminal coronary angioplasty can be detected by non-invasive procedures but their ability to predict later restenosis soon after a successful angioplasty as well as recurrence of angina has not been assessed. A maximal exercise test and myocardial thallium perfusion scintigraphy were, therefore, performed in 91 asymptomatic patients a median of 5 weeks after they had undergone a technically successful angioplasty. Primary success of the procedure was confirmed by the decrease in percentage diameter stenosis from 64(12)% to 30(13)% as measured from the coronary angiograms and in the trans-stenotic pressure gradient (normalised for mean aortic pressure) from 0.61(0.16) to 0.17(0.09). A clinical follow up examination (8.6(4.9) months later) was carried out in all patients and a late coronary angiogram obtained in 77. The thallium perfusion scintigram showing the presence or absence of a reversible defect was highly predictive for restenosis whereas the exercise test was not. The positive predictive value of an abnormal scintigram was 82% compared with 60% for the exercise test (ST segment depression/or angina or both at peak workload). Angina or a new myocardial infarction occurred in 60% of patients with abnormal and in 21% of patients with normal scintigrams.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3155619      PMCID: PMC481739          DOI: 10.1136/hrt.53.2.194

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  16 in total

1.  Estimation of the probability of exercise-induced ischemia by quantitative ECG analysis.

Authors:  M L Simoons; P G Hugenholtz
Journal:  Circulation       Date:  1977-10       Impact factor: 29.690

2.  Transluminal coronary angioplasty and early restenosis. Fibrocellular occlusion after wall laceration.

Authors:  C E Essed; M Van den Brand; A E Becker
Journal:  Br Heart J       Date:  1983-04

3.  Percutaneous transluminal coronary angioplasty: report from the Registry of the National Heart, Lung, and Blood Institute.

Authors:  K M Kent; L G Bentivoglio; P C Block; M J Cowley; G Dorros; A J Gosselin; A Gruntzig; R K Myler; J Simpson; S H Stertzer; D O Williams; L Fisher; M J Gillespie; K Detre; S Kelsey; S M Mullin; M B Mock
Journal:  Am J Cardiol       Date:  1982-06       Impact factor: 2.778

4.  Exercise electrocardiography and myocardial scintigraphy in the serial evaluation of the results of percutaneous transluminal coronary angioplasty.

Authors:  J M Scholl; B R Chaitman; P R David; G Dupras; G Brévers; P G Val; J Crépeau; J Lespérance; M G Bourassa
Journal:  Circulation       Date:  1982-08       Impact factor: 29.690

5.  Improved myocardial function during exercise after successful percutaneous transluminal coronary angioplasty.

Authors:  K M Kent; R O Bonow; D R Rosing; C J Ewels; L C Lipson; C L McIntosh; S Bacharach; M Green; S E Epstein
Journal:  N Engl J Med       Date:  1982-02-25       Impact factor: 91.245

6.  Short- and long-term changes in myocardial perfusion after percutaneous transluminal coronary angioplasty assessed by thallium-201 exercise scintigraphy.

Authors:  H O Hirzel; K Nuesch; A R Gruentzig; U M Luetolf
Journal:  Circulation       Date:  1981-05       Impact factor: 29.690

Review 7.  Thallium redistribution: mechanisms and clinical utility.

Authors:  G M Pohost; N M Alpert; J S Ingwall; H W Strauss
Journal:  Semin Nucl Med       Date:  1980-01       Impact factor: 4.446

8.  Noninvasive assessment of coronary stenoses by myocardial imaging during pharmacologic coronary vasodilatation. III. Clinical trial.

Authors:  P C Albro; K L Gould; R J Westcott; G W Hamilton; J L Ritchie; D L Williams
Journal:  Am J Cardiol       Date:  1978-11       Impact factor: 2.778

9.  Efficacy of percutaneous transluminal coronary angioplasty: technique, patient selection, salutary results, limitations and complications.

Authors:  M J Cowley; G W Vetrovec; T C Wolfgang
Journal:  Am Heart J       Date:  1981-03       Impact factor: 4.749

10.  Transluminal angioplasty: correlation of morphologic and angiographic findings in an experimental model.

Authors:  P C Block; K L Baughman; R C Pasternak; J T Fallon
Journal:  Circulation       Date:  1980-04       Impact factor: 29.690

View more
  7 in total

1.  Role of myocardial perfusion imaging after coronary revascularization in symptom-free patients: are low-risk patients really low?

Authors:  Dominick Joseph Angiolillo; Alessandro Giordano
Journal:  J Nucl Cardiol       Date:  2002 Sep-Oct       Impact factor: 5.952

2.  Nuclear cardiology: the interventionalists' perspective.

Authors:  H L Haronian; H S Cabin
Journal:  J Nucl Cardiol       Date:  1994 Jul-Aug       Impact factor: 5.952

3.  A comparative study of restenosis rates in bare metal and drug-eluting stents.

Authors:  Shilpi Mohan; Anil Dhall
Journal:  Int J Angiol       Date:  2010

4.  Assessing the success of percutaneous transluminal coronary angioplasty.

Authors:  P D Bourdillon
Journal:  Br Heart J       Date:  1987-09

Review 5.  Indications for routine heart-catheterization after CABG and PTCA.

Authors:  A Breeman; P W Serruys
Journal:  Int J Card Imaging       Date:  1993

Review 6.  Myocardial scintigraphy--25 years after start.

Authors:  G Hör
Journal:  Eur J Nucl Med       Date:  1988

7.  Assessment of percutaneous transluminal coronary angioplasty with 123IODO-heptadecanoic acid.

Authors:  P G Stoddart; M Papouchado; J Vann Jones; P Wilde
Journal:  Eur J Nucl Med       Date:  1987
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.